(Medical Xpress) -- It's a chilling thought--losing the sense of sight because of severe injury or damage to the brain's visual cortex. But, is it possible to train a damaged or injured brain to "see" again after such a catastrophic ...
Apr 3, 2012
Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation ...
Apr 3, 2012
Patients with breast cancer assigned to the HER2-based peptide vaccine AE37 had immunologic responses compared with a control group, according to 24-month results presented at the AACR Annual Meeting 2012, held here March ...
Apr 3, 2012
Peptide vaccination in children with gliomas was well tolerated with evidence of immunological and clinical responses, but some children experienced periods of immunological pseudoprogression, where tumors appeared larger ...
Apr 3, 2012
Maintenance therapy with interleukin-2 and 13-cis retinoic acid may be an inexpensive method for increasing survival in patients with a variety of stage 4 cancers, according to data reported at the AACR Annual Meeting 2012, ...
Apr 3, 2012
(Medical Xpress) -- Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet shows that when serious complications arise after surgery for ...
Apr 3, 2012
(Medical Xpress) -- Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant ...
Apr 3, 2012
